Protecting Trans Children: Scientific Uncertainty and Legal Debates Over...
By Marie-Amélie George A tweet turned Luna Younger’s personal struggle into a national controversy. Using 148 characters, Texas Governor Greg Abbott announced that the Texas Attorney General’s Office...
View ArticleGender-Affirming Care, Abortion, and the Politics of Science: A Response to...
By Aziza Ahmed On August 21, 2023, the 11th Circuit issued a decision that allowed a ban on transgender care to go into effect in Alabama. The Alabama ban, formally called the Alabama Vulnerable Child...
View ArticleCertainty and Uncertainty in Trans-Intersex Science Politics
By Maayan Sudai Joanna Wuest’s Born This Way: Science, Citizenship, and Inequality in the American LGBTQ+ Movement describes the evolution of the “born this way” framework through pivotal moments in...
View ArticleOn Searching for the Unknown with Unspeakable Names: Searching PubMed for...
By P.F. Anderson and LaTeesa James PubMed special queries are master search strategies on common, important, but challenging health topics, which are usually peer-reviewed. Disability certainly...
View ArticleA European Cancer Survivors’ Right to be Forgotten?
By Hannah van Kolfschooten and Mirko Faccioli There are currently over 12 million cancer survivors in Europe. Due to improving cancer screening methods and medical treatment, this number is expected to...
View ArticleOn Siri and Recognitive Violence
By Joshua A. Halstead As a disabled person who relies on speech recognition software to complete a range of daily writing tasks (from emails to book chapters), I am no stranger to the universe of voice...
View ArticleContext Matters: Affirmative Action, Public Health, and the Use of...
By Wendy E. Parmet, Elaine Marshall & Alisa K. Lincoln Last June, in Students for Fair Admissions (SFFA), the Supreme Court ruled that universities could not consider race in admitting students. In...
View ArticleWhat the Law and Bioethics Tell Us About Synthetic Human Embryos
By Barbara Pfeffer Billauer A synthetic embryo can now be constructed from very early pre-embryonic cells – without the need for an egg or sperm. These were initially created in mice. In April,...
View ArticleOrgan Transplant Candidates Who Use Medical Cannabis Face Discrimination
By Hannah Rahim Medical cannabis users in the U.S. face discrimination in seeking health care services, including restrictions against obtaining solid organ transplants. Considering growing evidence...
View ArticleThe Privatization of Cancer
By Daniel G. Aaron Cancer is fearsome, unstoppable even. So the story goes. Yes, you can secure some extra time with loved ones, and — if you are lucky — maybe your cancer is susceptible to drugs or...
View ArticleWhen the Law of Scientific Evidence Collides with Medical Practice
By Barbara Pfeffer Billauer Approaches to resolving scientific evidentiary issues continue to diverge throughout the country.[1] A prominent recent example includes the rejection of the medical...
View ArticleThe SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients
How Amgen v. Sanofi will affect innovation and the pharmaceutical industry. By Timothy Bonis Millions of patients rely on monoclonal antibodies. The global market in 2022 was $210B with a compound...
View ArticleHistory Rhymes with the Psychedelic Boom
By David Herzberg As a historian of psychoactive pharmaceuticals in the 20th century U.S., I see history rhyming in potentially dangerous ways in the current psychedelic boom. After decades of being...
View ArticleCommon Problems in Psychedelic Science, and How to Fix Them
By Eiko I. Fried and Michiel van Elk Much optimism has been expressed about the potential of psychedelics to treat mental health problems such as suicidal ideation, depression, and post-traumatic...
View ArticleWhen the Promises of a Policy Do Not Meet the Reality of Its Practice:...
By Tahlia Harrison As a practicing therapist in Oregon working with complex trauma survivors, I was optimistic at first about the passage in 2020 of Measure 109 and its promise of legalizing...
View ArticleClik here to view.
Beyond the Psychedelic Competitive Moat: Chasing the Patent Dragon
By Amanda Rose Pratt and Shahin Shams In the last five years, the granting of overly broad psychedelic patents led to the creation of the nonprofit online psychedelic prior art library Porta Sophia. As...
View ArticleA Brief Political Economy of Hype
By Maxim Tvorun-Dunn Silicon Valley depends on boom-and-bust cycles, manufacturing a new wave of investments every few months by promising grand technological revolutions, whether through AI,...
View ArticleShould a Psychedelic Therapist Be Able to Continue Therapy for Their Patients...
By Samuel Hatfield Psilocybin and MDMA were recently rescheduled in Australia for clinical use, leading many mental health professionals to question how psychedelic therapy will work in practice. As...
View ArticleLet Go and Surrender: Considerations on MDMA Couples Therapy and Coercive...
Note from Susannah Baruch, Petrie-Flom Center: Following this recent post in the Critical Psychedelic Studies symposium on the Bill of Health blog, two sets of researchers whose studies were described...
View ArticleR&D Mini-Me? New Legal Questions for Organoids
By Adithi Iyer I have written previously about the not-so-distant possibility and promise of regenerative medicine, an area concerned with therapies that encourage the body to repair or heal itself....
View Article
